# US 8,278,032 B2 · Transporter protein in mammal and utilization of the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,032 B2
- Document ID: US8278032B2
- Status: Granted
- Kind: B2
- Application number: 12/817,576
- Filed: 2010-06-17
- Published: 2010-11-04
- Granted: 2012-10-02
- Earliest claimed: 2005-10-14
- Assignees: Genomembrane, Inc.
- Inventors: Yoshinori Moriyama; Hiroshi Omote; Masato Otsuka; Takuya Matsumoto; Miki Hiasa
- Web page: https://patentgrep.com/patent/US8278032B2

## CPC

- C07K 14/705: Receptors; Cell surface antigens; Cell surface determinants {(tumour specific antigens C07K14/4748)}
- G01N 33/5432: {Liposomes or microcapsules}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention provides a lipid membrane that contains a polypeptide consisting of the amino acid sequence of SEQ ID NO: 2, 4, 6, 8, or 22. Use of the present invention enables screening for a chemical which regulates excretion of a chemical and/or a waste. Furthermore, use of the present invention enables an arbitrary chemical to be tested for nephrotoxicity and/or hepatotoxicity.

## Claims

### Claim 1

A method for preparing a lipid membrane preparation for use in an assay for a candidate substrate of a transporter polypeptide, said method comprising the steps of isolating a lipid membrane comprising a polypeptide comprising the amino acid sequence of SEQ ID NO:4 from a host cell expressing said polypeptide, and incubating said lipid membrane with a substrate of said polypeptide, wherein the substrate is transported across said lipid membrane by said polypeptide, thereby preparing said lipid membrane preparation.

### Claim 2

A kit for preparing a lipid membrane preparation, said kit comprising a vector containing a polynucleotide encoding a polypeptide comprising the amino acid sequence of SEQ ID NO: 4 and a substrate of said polypeptide, wherein the substrate is transported across said lipid membrane by said polypeptide and wherein the substrate is selected from the group consisting of tetraethylammonium (TEA), 1-methyl-4-phenylpyridinium (MPP), nicotine, cimetidine, quinidine, verapamil, quinine, melatonin, steroid hormones, excreted chemical, waste, corticosterone, Rhodamine 123, testosterone, progesterone, androsterone, quercetin, Rhodamine 6G, chloroquine, pyrimethamine, chlorpromazine, berberine, cisplatin, propranolol, papaverine, and thiamin.

### Claim 3

A method for screening for a candidate substrate of a transporter polypeptide comprising the steps of incubating an isolated lipid membrane containing a transporter polypeptide comprising the amino acid sequence of SEQ ID NO: 4 with a candidate substrate; determining whether said candidate substrate is transported by the transporter polypeptide across said isolated lipid membrane; and identifying a candidate substrate that is transported by the transporter polypeptide as a substrate of the transporter polypeptide.

### Claim 4 (depends on 3)

The method according to claim 3, further comprising a step of providing a pH gradient wherein pH decreases towards the direction to which the candidate substrate is transported, between the two domains subdivided by the lipid membrane.

### Claim 5 (depends on 4)

The method according to claim 4, wherein the lipid membrane forms a vesicle in which the inner pH is lower than the outer pH.

### Claim 6 (depends on 5)

The method according to claim 5, wherein the pH inside the vesicle is 6.5-7.5, and the pH outside the vesicle is 8.0-8.5.

### Claim 7 (depends on 3, 4, 5, 6)

The method according to any one of claims 3 to 6, wherein the lipid membrane further comprises H+-ATPase protein.

### Claim 8

A kit for screening for a candidate substrate of a transporter polypeptide, said kit comprising an isolated lipid membrane containing a transporter polypeptide comprising the amino acid sequence of SEQ ID NO: 4 and a substrate of said polypeptide, wherein the substrate is transported across said lipid membrane by said polypeptide and wherein the substrate is selected from the group consisting of tetraethylammonium (TEA), 1-methyl-4-phenylpyridinium (MPP), nicotine, cimetidine, quinidine, verapamil, quinine, melatonin, steroid hormone, excreted chemical, waste, corticosterone, Rhodamine 123, testosterone, progesterone, androsterone, quercetin, Rhodamine 6G, chloroquine, pyrimethamine, chlorpromazine, berberine, cisplatin, propranolol, papaverine, and thiamin.

### Claim 9 (depends on 8)

The kit according to claim 8, wherein the isolated lipid membrane further comprises H+-ATPase protein.

### Claim 10

A method for screening for a candidate chemical which regulates substrate transport across a cell membrane via a transporter polypeptide, comprising the steps of incubating an isolated lipid membrane containing a polypeptide comprising the amino acid sequence of SEQ ID NO:4 together with the substrate of said polypeptide, wherein the substrate is transported across the membrane by said polypeptide, and the candidate chemical; determining whether substrate transport is regulated by said candidate chemical; and identifying a candidate chemical that regulates substrate transport as a chemical regulator of substrate transport.

### Claim 11 (depends on 10)

The method according to claim 10, wherein the substrate is selected from the group consisting of tetraethylammonium (TEA), 1-methyl-4-phenylpyridinium (MPP), nicotine, cimetidine, quinidine, verapamil, quinine, melatonin, steroid hormone, excreted chemical, waste, corticosterone, Rhodamine 123, testosterone, progesterone, androsterone, quercetin, Rhodamine 6G, chloroquine, pyrimethamine, chlorpromazine, berberine, cisplatin, propranolol, papaverine, and thiamin.

### Claim 12 (depends on 10)

The method according to claim 10, further comprising a step of providing a pH gradient wherein pH decreases towards the direction to which the substrate is transported, between the two domains subdivided by the lipid membrane.

### Claim 13 (depends on 12)

The method according to claim 12, wherein the lipid membrane forms a vesicle in which the inner pH is lower than the outer pH.

### Claim 14 (depends on 13)

The method according to claim 13, wherein the pH inside the vesicle is 6.5-7.5, and the pH outside the vesicle is 8.0-8.5.

### Claim 15 (depends on 10, 11, 12, 13, 14)

The method according to any one of claims 10 to 14, wherein the lipid membrane further comprises H+-ATPase protein.

### Claim 16 (depends on 1)

The method of claim 1, wherein the polypeptide consists of the amino acid sequence of SEQ ID NO: 4.

### Claim 17 (depends on 2)

The kit of claim 2, wherein the polypeptide consists of the amino acid sequence of SEQ ID NO: 4.

### Claim 18 (depends on 8)

The kit of claim 8, wherein the polypeptide consists of the amino acid sequence of SEQ ID NO: 4.
